David Feliciano

Dr. David Feliciano

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2015 in Cold Spring Harbor Perspectives in Biology
Verified
Journal Article
Open access
PDF file
DFDavid Feliciano
David Feliciano
ABAngeligue Bordey
Angeligue Bordey
Luca BonfantiLuca Bonfanti
Luca Bonfanti
Two decades after the discovery that neural stem cells (NSCs) populate some regions of the mammalian central nervous system (CNS), deep knowledge has been accumulated on their capacity to generate new neurons in the adult brain. This constitutive adult neurogenesis occurs throughout life primarily within remnants of the embryonic germinal layers known as “neurogenic sites.” Nevertheless, some processes of neurogliogenesis also occur in the CNS parenchyma commonly considered as “nonneurogenic.” This “noncanonical” cell genesis has been the object of many claims, some of which turned out to be not true. Indeed, it is often an “incomplete” process as to its final outcome, heterogeneous by several measures, including regional location, progenitor identity, and fate of the progeny. These aspects also strictly depend on the animal species, suggesting that persistent neurogenic processes have uniquely adapted to the brain anatomy of different mammals. Whereas some examples of noncanonical neurogenesis are strictly parenchymal, others also show stem cell niche-like features and a strong link with the ventricular cavities. This work will review results obtained in a research field that expanded from classic neurogenesis studies involving a variety of areas of the CNS outside of the subventricular zone (SVZ) and subgranular zone (SGZ). It will be highlighted how knowledge concerning noncanonical neurogenic areas is still incomplete owing to its regional and species-specific heterogeneity, and to objective difficulties still hampering its full identification and characterization.

1 April 2011 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
DFDavid Feliciano
David Feliciano
TSTiffany Su
Tiffany Su
JLJean Lopez
Jean Lopez
JPJean-Claude Platel
Jean-Claude Platel
ABAngeligue Bordey
Angeligue Bordey
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by mutations in Tsc1 or Tsc2 that lead to mammalian target of rapamycin (mTOR) hyperactivity. Patients with TSC suffer from intractable seizures resulting from cortical malformations known as tubers, but research into how these tubers form has been limited because of the lack of an animal model. To address this limitation, we used in utero electroporation to knock out Tsc1 in selected neuronal populations in mice heterozygous for a mutant Tsc1 allele that eliminates the Tsc1 gene product at a precise developmental time point. Knockout of Tsc1 in single cells led to increased mTOR activity and soma size in the affected neurons. The mice exhibited white matter heterotopic nodules and discrete cortical tuber-like lesions containing cytomegalic and multinucleated neurons with abnormal dendritic trees resembling giant cells. Cortical tubers in the mutant mice did not exhibit signs of gliosis. Furthermore, phospho-S6 immunoreactivity was not upregulated in Tsc1-null astrocytes despite a lower seizure threshold. Collectively, these data suggest that a double-hit strategy to eliminate Tsc1 in discrete neuronal populations generates TSC-associated cortical lesions, providing a model to uncover the mechanisms of lesion formation and cortical hyperexcitability. In addition, the absence of glial reactivity argues against a contribution of astrocytes to lesion-associated hyperexcitability.

1 October 2013 in Cell Reports
Verified
Journal Article
Open access
NHNathaniel Hartman
Nathaniel Hartman
TLTiffany V. Lin
Tiffany V. Lin
LZLongbo Zhang
Longbo Zhang
GPGrace E. Paquelet
Grace E. Paquelet
DFDavid Feliciano
David Feliciano
ABAngeligue Bordey
Angeligue Bordey
The mammalian target of rapamycin complex 1 (mTORC1) integrates signals important for cell growth, and its dysregulation in neural stem cells (NSCs) is implicated in several neurological disorders associated with abnormal neurogenesis and brain size. However, the function of mTORC1 on NSC self-renewal and the downstream regulatory mechanisms are ill defined. Here, we found that genetically decreasing mTORC1 activity in neonatal NSCs prevented their differentiation, resulting in reduced lineage expansion and aborted neuron production. Constitutive activation of the translational repressor 4E-BP1, which blocked cap-dependent translation, had similar effects and prevented hyperactive mTORC1 induction of NSC differentiation and promoted self-renewal. Although 4E-BP2 knockdown promoted NSC differentiation, p70 S6 kinase 1 and 2 (S6K1/S6K2) knockdown did not affect NSC differentiation but reduced NSC soma size and prevented hyperactive mTORC1-induced increase in soma size. These data demonstrate a crucial role of mTORC1 and 4E-BP for switching on and off cap-dependent translation in NSC differentiation.

1 April 2018 in Cell Reports
Verified
Journal Article
Open access
MMMary C. Morton
Mary C. Morton
VNVictoria N. Neckles
Victoria N. Neckles
CSCaitlin M. Seluzicki
Caitlin M. Seluzicki
JHJennie C. Holmberg
Jennie C. Holmberg
DFDavid Feliciano
David Feliciano
Subventricular zone (SVZ) neural stem cells (NSCs) are the cornerstone of the perinatal neurogenic niche. Microglia are immune cells of the nervous system that are enriched in the neonatal SVZ. Although microglia regulate NSCs, the extent to which this interaction is bi-directional is unclear. Extracellular vesicles (EVs) are cell-derived particles that encase miRNA and proteins. Here, we demonstrate that SVZ NSCs generate and release EVs. Neonatal electroporated fluorescent EV fusion proteins were released by NSCs and subsequently cleared from the SVZ. EVs were preferentially targeted to microglia. Small RNA sequencing identified miRNAs within the EVs that regulate microglia physiology and morphology. EVs induced a transition to a CD11b/Iba1 non-stellate microglial morphology. The transition accompanied a microglial transcriptional state characterized by Let-7-regulated cytokine release and a negative feedback loop that controlled NSC proliferation. These findings implicate an NSC-EV-microglia axis and provide insight to normal and pathophysiological brain development.

26 February 2013 in International Journal of Developmental Neuroscience
Verified
Journal Article
Closed access
DFDavid Feliciano
David Feliciano
TLTiffany V. Lin
Tiffany V. Lin
NHNathaniel Hartman
Nathaniel Hartman
CBChristopher M. Bartley
Christopher M. Bartley
CKCathryn Kubera
Cathryn Kubera
ABAngeligue Bordey
Angeligue Bordey

12 February 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DFDavid Feliciano
David Feliciano
SZShiliang Zhang
Shiliang Zhang
CNCarole M. Nasrallah
Carole M. Nasrallah
SLSteven N. Lisgo
Steven N. Lisgo
ABAngeligue Bordey
Angeligue Bordey
During brain development, neural stem cells (NSCs) receive on-or-off signals important for regulating their amplification and reaching adequate neuron density. However, how a coordinated regulation of intracellular pathways and genetic programs is achieved has remained elusive. Here, we found that the embryonic (e) CSF contains 1012 nanoparticles/ml (77 nm diameter), some of which were identified as exosome nanovesicles that contain evolutionarily conserved molecules important for coordinating intracellular pathways. eCSF nanovesicles collected from rodent and human embryos encapsulate protein and microRNA components of the insulin-like growth factor (IGF) signaling pathway. Supplementation of eCSF nanovesicles to a mixed culture containing eNSCs activated the IGF-mammalian target of rapamycin complex 1 (mTORC1) pathway in eNSCs and expanded the pool of proliferative eNSCs. These data show that the eCSF serves as a medium for the distribution of nanovesicles, including exosomes, and the coordinated transfer of evolutionary conserved molecules that regulate eNSC amplification during corticogenesis.